NHS Staff Stage Silent Rebellion Against Palantir's Health Data Platform
In a significant development within the UK's healthcare system, National Health Service (NHS) staff are actively refusing to work with Palantir Technologies' controversial health data platform. According to exclusive reporting by The Financial Times, this resistance has reached a point where some employees have formally requested hospital administrators to assign them alternative roles, citing profound ethical concerns about the American technology company.
The £330 Million Contract Sparking Controversy
The conflict centers around Palantir's substantial £330 million contract awarded in 2023 to develop and implement the Federated Data Platform (FDP). This ambitious system is designed to consolidate diverse NHS operational data streams, including critical information about patient waiting lists, staffing allocations, patient records, and operating theatre schedules. The platform represents a major technological investment aimed at streamlining healthcare operations across England's national health service.
However, Palantir's involvement has drawn intense scrutiny due to the company's extensive work with United States defense and intelligence agencies, coupled with controversial political statements from company leadership. Particular attention has focused on co-founder and chief executive Alex Karp's public support for former President Donald Trump's immigration policies, creating what many NHS staff perceive as an ethical conflict with the values of public healthcare.
"I Refuse to Work on This Software": Inside the NHS Resistance
One senior NHS official responsible for managing data analysts provided a stark assessment to The Financial Times: "People are saying, 'I refuse to work on this software. You have to find something else for me to do'. They're calling it a workplace adjustment. It would be like, you know, if you were disabled and needed a different desk, they're literally treating it like that."
The official further revealed that while a significant number of staff have taken this formal stance, "there is also a silent majority that feel uncomfortable but wouldn't want to put their head above a parapet." This suggests the discontent may be more widespread than official records indicate.
Another senior health official with nearly two decades of NHS analytics experience expressed even stronger opposition, declaring they would not use the FDP because it is operated by what they described as an "ethically bankrupt" organization. "I will continue to refuse to engage with any work involving this company. I know that there are staff who are already working as slowly as they can when pressured to work with Palantir," the official added, revealing passive resistance tactics among some employees.
A junior NHS staff member confirmed this pattern, telling reporters: "Last year, I contacted my team lead to officially refuse to work with the FDP and I was told that I would be found projects outside of the FDP wherever possible."
Political and Institutional Concerns Mount
The ethical objections have transcended individual staff concerns, reaching the highest levels of British governance. Members of Parliament, NHS employee unions, and medical trade organizations have all raised questions about Palantir's suitability for handling sensitive national health data. The Financial Times recently reported that UK government ministers have sought legal advice about potentially activating a break clause in Palantir's contract amid mounting pressure to remove the company from NHS England's data infrastructure.
One health data official explained their team's approach: "We're not interested in using [the FDP] as it doesn't do anything new for us" and revealed that "their method is to just not use it." The official elaborated: "It's a mix of not needing to because other methods are better, and ethics. It makes me feel sick every time I log into the thing and I know I'm not alone in that. Colleagues are avoiding the news because it makes them feel terrible."
Official Responses and Political Dimensions
Louis Mosley, Palantir's UK chief, defended the company's position in a statement to The Times UK: "Having a review clause in a contract is good and normal practice. However, what some ideologically motivated campaigners are suggesting should happen would harm patient care and prevent some of the biggest challenges facing the NHS from being tackled."
Internal documents obtained through a Freedom of Information request by digital rights group Foxglove reveal the political sensitivity surrounding the issue. A briefing prepared for Health Secretary Wes Streeting ahead of a June 2025 meeting with Mosley stated: "The public perception of the FDP during the procurement, and then in delivery, has been affected by the profile of Palantir. We do not know the extent to which this is impacting on delivery. It is, however, likely to make it harder to go further with the FDP, and to encourage the inclusion of GP data locally. It may be useful to consider ways in which we can mitigate this."
During a recent appearance on the Guardian Politics Weekly podcast, Streeting acknowledged the ethical concerns: "Yes, for a few reasons. Firstly, when you look at some of the things that Palantir's leaders have said in the States, when you look at their political views and their outlook." When specifically asked about co-founder Peter Thiel's support for Donald Trump, Streeting responded: "If you were to put him and some of those Palantir bosses on the political spectrum in the UK, they would be well off to the right of even Kemi Badenoch's Conservative Party, which is saying something at the moment. And so there's a question people have about values."
Institutional Assurances and Counterarguments
An NHS spokesperson sought to reassure the public about data governance: "All suppliers, including Palantir, and their staff operate only under NHS instruction, with all data access remaining under NHS control and governed by strict contractual confidentiality obligations."
A Palantir spokesperson addressed the staff concerns directly: "We are happy to discuss any concerns from NHS staff, and there is a lot of false information circulating about the company and how our software works. It is also important to understand that the evidence of the past two years of delivery is that our software is helping improve patient care."
This developing situation represents a significant challenge for NHS leadership, balancing technological advancement with staff ethics and public trust. The silent rebellion among healthcare data professionals highlights growing concerns about the intersection of technology, ethics, and public health infrastructure in an increasingly polarized political landscape.
